Our purpose is to SOLVE FSHD2 while further benefiting FSHD1. We will do this by removing barrriers and accelerating drug development for FSHD.Our Plan
SOLVE FSHD is a venture philanthropic organization founded on the generous commitment of $100M USD from the Wilson family. We are part of a larger global FSHD community that has brought us to a place and time where cures for FSHD are possible. As a mission-driven organization, our unique approach is to be a catalyst, making strategic investments through partners in leading academic, biotech and biopharmaceutical organizations.
We will work with our partners and advisors in the life sciences community to develop a pipeline of new therapies and a cure by 2027. Once we have a SOLVE for FSHD we will continue to support the ongoing needs of this global community.
Funded to Date
We’re focused on funding research and clinical trials, partnering with academics and biotech companies. We fund bottlenecks and we fund what otherwise would not get funded after a rigorous assessment. Additional details on our annual goals, funding mechanisms and investments will be announced in January, 2022.